Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Lendingtree stock
Learn how to easily invest in Lendingtree stock.
Lendingtree Inc is a financial conglomerates business based in the US. Lendingtree shares (TREE) are listed on the NASDAQ and all prices are listed in US Dollars. Lendingtree employs 1,407 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Lendingtree
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TREE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Lendingtree stock price (NASDAQ: TREE)Use our graph to track the performance of TREE stocks over time.
Lendingtree shares at a glance
|Latest market close||$46.08|
|52-week range||$43.00 - $217.02|
|50-day moving average||$63.87|
|200-day moving average||$110.68|
|Wall St. target price||$105.75|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$2.94|
Buy Lendingtree shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Lendingtree stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Lendingtree price performance over time
|1 week (2022-06-28)||-2.83%|
|1 month (2022-06-02)||-27.83%|
|3 months (2022-04-05)||-63.04%|
|6 months (2022-01-06)||-64.39%|
|1 year (2021-07-06)||-78.15%|
|2 years (2020-07-06)||-84.91%|
|3 years (2019-07-05)||415.3|
|5 years (2017-07-06)||167.15|
Is Lendingtree stock undervalued or overvalued?
Valuing Lendingtree stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Lendingtree's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Lendingtree's P/E ratio
Lendingtree's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Lendingtree shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Lendingtree's PEG ratio
Lendingtree's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.5488. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Lendingtree's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Lendingtree's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $47.1 million.
The EBITDA is a measure of a Lendingtree's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||0.18%|
|Gross profit TTM||$1 billion|
|Return on assets TTM||0.1%|
|Return on equity TTM||11.68%|
|Market capitalisation||$588.2 million|
TTM: trailing 12 months
Lendingtree share dividends
We're not expecting Lendingtree to pay a dividend over the next 12 months.
Lendingtree share price volatility
Over the last 12 months, Lendingtree's shares have ranged in value from as little as $43 up to $217.02. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lendingtree's is 1.6162. This would suggest that Lendingtree's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
LendingTree, Inc. , through its subsidiary, LT Intermediate Company, LLC, operates online consumer platform in the United States. It operates through three segments: Home, Consumer, and Insurance. The Home segment offers purchase mortgage, refinance mortgage, reverse mortgage, and home equity loans; lines of credit; and real estate brokerage services. The Consumer segment provides credit cards; personal, small business, student, and auto loans; deposit accounts; and other credit products, such as credit repair and debt settlement services. The Insurance segment includes information, tools, and access to insurance quote products, including home and automobile, through which consumers are matched with insurance lead aggregators to obtain insurance offers. LendingTree, Inc.
Lendingtree in the news
Why Greensboro ranks ninth among franchise ownership nationally
Credit card interest rates are ‘the highest they’ve ever been’: Analyst
Tens of millions of Americans could see their credit scores improve as medical collection debt is removed from reports
Frequently asked questionsWhat percentage of Lendingtree is owned by insiders or institutions?
Currently 15.114% of Lendingtree shares are held by insiders and 85.841% by institutions. How many people work for Lendingtree?
Latest data suggests 1,407 work at Lendingtree. When does the fiscal year end for Lendingtree?
Lendingtree's fiscal year ends in December. Where is Lendingtree based?
Lendingtree's address is: 1415 Vantage Park Drive, Charlotte, NC, United States, 28203 What is Lendingtree's ISIN number?
Lendingtree's international securities identification number is: US52603B1070 What is Lendingtree's CUSIP number?
Lendingtree's Committee on Uniform Securities Identification Procedures number is: 52603B107
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert